Denali Therapeutics (D2NL34.SA) Q1 2025 Earnings

27FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-4.66
-4.24
-3.81
-3.38

Details

Expected EPS
-4.664164005000001
Actual EPS
-3.9121300000000003
Surprise EPS
0.75
Surprise Percent
+16.12%

Description

Denali Therapeutics (D2NL34.SA) has reported earnings of -3.9121300000000003 per share for Q1 2025.

0 Comments

Share your thoughts